Amir Lebastchi, MD (@amirlebastchi) 's Twitter Profile
Amir Lebastchi, MD

@amirlebastchi

Assistant Professor of Urology @USC_Urology| Trained @theNCI, @UmichUrology and @YaleSurgery| RT and ❤️ ≠ Endorsement

ID: 723350276418224129

calendar_today22-04-2016 03:18:39

994 Tweet

1,1K Followers

921 Following

Dr. René Sotelo (@doctorsotelo) 's Twitter Profile Photo

The Catherine & Joseph Aresty Department of Urology at the University of Southern California (USC) stands at the cutting-edge of clinical care, basic research, and surgical excellence. Our large and multi-talented team is constantly striving to innovate surgical techniques and

The Catherine & Joseph Aresty Department of Urology at the University of Southern California (USC) stands at the cutting-edge of clinical care, basic research, and surgical excellence. Our large and multi-talented team is constantly striving to innovate surgical techniques and
Hashim U. Ahmed (@londonprostate1) 's Twitter Profile Photo

I thought the actual final PREVENT results showed a lower infection risk with Transperineal so that attribute should be to the right of the scales favouring transperineal 0% TP vs 1.6% TR, p=0.02 jamanetwork.com/journals/jamao…

Dr Andre Abreu (@aldcabreu) 's Twitter Profile Photo

We're excited to host the first Robotic Focal HIFU Masterclass for Prostate Cancer on April 24-25 at USC Urology, Los Angeles! Live Focal One cases, hands-on training and expert lectures. Spots filling fast—register now: events.focalone.com/usc-masterclas… Amir Lebastchi, MD

Dr. Giovanni E Cacciamani MD MSc FEBU 🇮🇹🇺🇸🇪🇺 (@cacciamani_md) 's Twitter Profile Photo

Congratulations to the amazing, fantastic, and truly unbelievable Chinchilla Joan real soul of USC Urology on this incredible achievement! Your hard work and brilliance continue to inspire everyone around you — so well deserved!

Congratulations to the amazing, fantastic, and truly unbelievable <a href="/jmm869127/">Chinchilla Joan</a> real soul of <a href="/USC_Urology/">USC Urology</a> on this incredible achievement! Your hard work and brilliance continue to inspire everyone around you — so well deserved!
Dr Andre Abreu (@aldcabreu) 's Twitter Profile Photo

Experience the future of prostate cancer treatment at the Masterclass in Robotic HIFU, April 24–25! Don’t miss a live Focal One procedure by focal therapy expert Amir Lebastchi, MD, MD for a real-time look at cutting-edge HIFU. USC Urology Register: events.focalone.com/usc-masterclas…

Vignesh Packiam, MD (@vigneshpackiam) 's Twitter Profile Photo

Just in time for AUA - A high-quality succinct review on contemporary intravesical therapy on NMIBC by the great Saum Ghodoussipour & all ⭐️ colleagues in European Urology Beautiful figures too! A valuable resource for patients & urologists Bladder Cancer Advocacy Network YUO pubmed.ncbi.nlm.nih.gov/40253283/

Just in time for AUA - A high-quality succinct review on contemporary intravesical therapy on NMIBC by the great <a href="/saumyg/">Saum Ghodoussipour</a> &amp; all ⭐️ colleagues in <a href="/EUplatinum/">European Urology</a>  

Beautiful figures too!

A valuable resource for patients &amp; urologists <a href="/BladderCancerUS/">Bladder Cancer Advocacy Network</a> <a href="/SUO_YUO/">YUO</a>

pubmed.ncbi.nlm.nih.gov/40253283/
Dr Andre Abreu (@aldcabreu) 's Twitter Profile Photo

The inaugural Masterclass in Robotic HIFU for Prostate Cancer is only one day away! We are excited to have focal therapy experts Pierre Halteh, MD, Amir Lebastchi, MD, MD, Behfar Ehdaie and Pr. Sebastien Crouzet share their personal experience. USC Urology Focal One

Focal Therapy Society (@focalsociety) 's Twitter Profile Photo

Focal therapy enters the chat! At SUO mtg Society of Urologic Oncology #AUA25 Focal Therapy is included with the orthodox standards of AS, RT and surgery. Amir Lebastchi, MD makes a compelling case for #focaltherapy, with Scott Eggener Bogdana Schmidt MD, MPH and Sophia Kamran highlighting the many choices for men

Focal therapy enters the chat!  At SUO mtg <a href="/UroOnc/">Society of Urologic Oncology</a> #AUA25 Focal Therapy is included with the orthodox standards of AS, RT and surgery. <a href="/AmirLebastchi/">Amir Lebastchi, MD</a> makes a compelling case for #focaltherapy, with <a href="/uroegg/">Scott Eggener</a> <a href="/BogdanaSchmidt/">Bogdana Schmidt MD, MPH</a> and Sophia Kamran highlighting the many choices for men
Wei Phin Tan, MD, MHS (@drtanwp) 's Twitter Profile Photo

Amir Lebastchi, MD shows why focal therapy is preferred for favorable intermediate-risk prostate cancer: •Radical tx doesn’t lower mortality •Hurts QOL •50% of patients on AS ends up getting treated by 8 years Focal therapy = effective, less invasive, better QOL. #AUA25 Society of Urologic Oncology

<a href="/AmirLebastchi/">Amir Lebastchi, MD</a> shows why focal therapy is preferred for favorable intermediate-risk prostate cancer:
•Radical tx doesn’t lower mortality
•Hurts QOL
•50% of patients on AS ends up getting treated by 8 years
Focal therapy = effective, less invasive, better QOL. #AUA25 <a href="/UroOnc/">Society of Urologic Oncology</a>
Hashim U. Ahmed (@londonprostate1) 's Twitter Profile Photo

Alexander Kenigsberg John Rewcastle, PhD Focal Therapy Society Focal One Profound Medical There isn’t another way, as John knows! Can’t use mets/survival/PSA/biopsy/function! Transition to a ‘salvage’ approach with objective criteria, bespoke to each initial treatment, to control against physician bias is only realistic way

Sandeep Gurram (@sandeepgurrammd) 's Twitter Profile Photo

Excited to share our work performed at National Cancer Institute addressing needs of rare hereditary kidney cancer through bench to bedside work Bevacizumab + erlotinib for #HLRCC assoc RCC 📍Response rate 72% 📍mPFS 21.1 mo Thanks to the patients who supported the study! nejm.org/doi/full/10.10…

Excited to share our work performed at <a href="/theNCI/">National Cancer Institute</a> addressing needs of rare hereditary kidney cancer through bench to bedside work

Bevacizumab + erlotinib for #HLRCC assoc RCC
📍Response rate 72%
📍mPFS 21.1 mo

Thanks to the patients who supported the study!
nejm.org/doi/full/10.10…